Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura.
Weisinger J, Bouzid R, Ranta D, Woaye-Hune P, Cohen-Aubart F, Gaible C, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P.
Weisinger J, et al. Among authors: coppo p.
Br J Haematol. 2024 Sep 4. doi: 10.1111/bjh.19752. Online ahead of print.
Br J Haematol. 2024.
PMID: 39228246